TrialFrontiers in immunology2021

Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma.

Jenny Bulgarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.